Using rare mutations to guide treatment options for drug resistant melanoma

Date 10 September 2017
Event ESMO 2017 Congress
Session ESMO-EORTC-EACR: Tumours with rare oncogenic lesions: From pre-clinical to clinical validation
Topics Melanoma and other Skin Tumours
Personalised Medicine
Presenter Richard Marais
Authors R. Marais
  • University Of Manchester, CRUK Manchester Institute, 00 - Manchester/GB